Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies Confirms Closure of ABI's Connecticut Corporate Offices

NEW YORK (GenomeWeb News) – Life Technologies, the recently merged combination of Invitrogen and Applied Biosystems, confirmed for GenomeWeb Daily News today that it will close ABI’s corporate offices in Norwalk, Conn., as part of efforts to eliminate redundant operations.
The firm will shutter the facility in July 2009, and corporate functions at that site will be transitioned to other locations between this month and then, according to a Life Technologies spokesperson. The firm did not disclose how many positions would be eliminated as part of the closure, but several local media outlets in Connecticut reported that around 100 jobs will be lost as a result. Life Technologies also has not disclosed how many jobs would be transferred to other offices.
In advance of the completion of the merger, Invitrogen said in October that it expects $80 million in synergies, mostly from cost savings, in the first year after closing the deal. Part of those synergies were expected to come from corporate overhead reductions, “which unfortunately does include the elimination of redundant positions between the two companies,” the spokesperson said in an e-mail today.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.